Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bigaud

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|November 19, 2013
Second generation S1P pathway modulators: research strategies and clinical developmentsMarc Bigaud, Danilo Guerini, Andreas Billich, et al.
Journal of Pharmacological and Toxicological Methods|September 24, 2004
A simple method to optimize peripheral blood mononuclear cell preparation from cynomolgus monkeys and improve mixed lymphocyte reactionsMarc Bigaud, Claudine Maurer, Corrine Vedrine, et al.
Neurology and Therapy|May 17, 2023
Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?Marc Bigaud, Pamela Ramseier, Sarah Tisserand, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Transplantation-induced functional/morphological changes in rat aorta allografts differ from those in arteries of rat kidney allograftsEmile Andriambeloson, Catherine Cannet, Charles Pally, et al.
Chemmedchem|February 1, 2011
BZM055, an iodinated radiotracer candidate for PET and SPECT imaging of myelin and FTY720 brain distributionEmmanuelle Briard, David Orain, Christian Beerli, et al.
International Journal of Molecular Sciences|November 26, 2022
Impact of Siponimod on Enteric and Central Nervous System Pathology in Late-Stage Experimental Autoimmune EncephalomyelitisAlicia Weier, Michael Enders, Philipp Kirchner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejectionBarbara Metzler, Patrick Gfeller, Marc Bigaud, et al.
Transplantation|December 20, 2011
Sotrastaurin (AEB071) alone and in combination with cyclosporine A prolongs survival times of non-human primate recipients of life-supporting kidney allograftsMarc Bigaud, Grazyna Wieczorek, Christian Beerli, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2008
Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivoGebhard Thoma, Christian Beerli, Marc Bigaud, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2021
Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insightsMarc Bigaud, Bettina Rudolph, Emmanuelle Briard, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|November 19, 2013
Second generation S1P pathway modulators: research strategies and clinical developmentsMarc Bigaud, Danilo Guerini, Andreas Billich, et al.
Journal of Pharmacological and Toxicological Methods|September 24, 2004
A simple method to optimize peripheral blood mononuclear cell preparation from cynomolgus monkeys and improve mixed lymphocyte reactionsMarc Bigaud, Claudine Maurer, Corrine Vedrine, et al.
Neurology and Therapy|May 17, 2023
Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?Marc Bigaud, Pamela Ramseier, Sarah Tisserand, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Transplantation-induced functional/morphological changes in rat aorta allografts differ from those in arteries of rat kidney allograftsEmile Andriambeloson, Catherine Cannet, Charles Pally, et al.
Chemmedchem|February 1, 2011
BZM055, an iodinated radiotracer candidate for PET and SPECT imaging of myelin and FTY720 brain distributionEmmanuelle Briard, David Orain, Christian Beerli, et al.
International Journal of Molecular Sciences|November 26, 2022
Impact of Siponimod on Enteric and Central Nervous System Pathology in Late-Stage Experimental Autoimmune EncephalomyelitisAlicia Weier, Michael Enders, Philipp Kirchner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejectionBarbara Metzler, Patrick Gfeller, Marc Bigaud, et al.
Transplantation|December 20, 2011
Sotrastaurin (AEB071) alone and in combination with cyclosporine A prolongs survival times of non-human primate recipients of life-supporting kidney allograftsMarc Bigaud, Grazyna Wieczorek, Christian Beerli, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2008
Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivoGebhard Thoma, Christian Beerli, Marc Bigaud, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2021
Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insightsMarc Bigaud, Bettina Rudolph, Emmanuelle Briard, et al.
Pageof 3